S&P 500   4,124.49 (-0.38%)
DOW   32,798.30 (-0.10%)
QQQ   316.20 (-1.41%)
AAPL   164.01 (-0.52%)
MSFT   279.09 (-0.44%)
META   167.38 (-1.69%)
GOOGL   115.95 (-1.15%)
AMZN   136.83 (-1.85%)
TSLA   853.33 (-2.06%)
NVDA   170.96 (-3.92%)
NIO   19.37 (-3.97%)
BABA   92.07 (+1.35%)
AMD   96.21 (-3.86%)
MU   58.63 (-4.59%)
T   18.17 (+0.94%)
CGC   3.02 (-7.93%)
GE   75.82 (+0.85%)
F   15.50 (-1.77%)
DIS   107.34 (-1.62%)
AMC   22.92 (-4.34%)
PYPL   94.24 (-2.10%)
PFE   49.78 (+0.42%)
NFLX   226.61 (-2.95%)
S&P 500   4,124.49 (-0.38%)
DOW   32,798.30 (-0.10%)
QQQ   316.20 (-1.41%)
AAPL   164.01 (-0.52%)
MSFT   279.09 (-0.44%)
META   167.38 (-1.69%)
GOOGL   115.95 (-1.15%)
AMZN   136.83 (-1.85%)
TSLA   853.33 (-2.06%)
NVDA   170.96 (-3.92%)
NIO   19.37 (-3.97%)
BABA   92.07 (+1.35%)
AMD   96.21 (-3.86%)
MU   58.63 (-4.59%)
T   18.17 (+0.94%)
CGC   3.02 (-7.93%)
GE   75.82 (+0.85%)
F   15.50 (-1.77%)
DIS   107.34 (-1.62%)
AMC   22.92 (-4.34%)
PYPL   94.24 (-2.10%)
PFE   49.78 (+0.42%)
NFLX   226.61 (-2.95%)
S&P 500   4,124.49 (-0.38%)
DOW   32,798.30 (-0.10%)
QQQ   316.20 (-1.41%)
AAPL   164.01 (-0.52%)
MSFT   279.09 (-0.44%)
META   167.38 (-1.69%)
GOOGL   115.95 (-1.15%)
AMZN   136.83 (-1.85%)
TSLA   853.33 (-2.06%)
NVDA   170.96 (-3.92%)
NIO   19.37 (-3.97%)
BABA   92.07 (+1.35%)
AMD   96.21 (-3.86%)
MU   58.63 (-4.59%)
T   18.17 (+0.94%)
CGC   3.02 (-7.93%)
GE   75.82 (+0.85%)
F   15.50 (-1.77%)
DIS   107.34 (-1.62%)
AMC   22.92 (-4.34%)
PYPL   94.24 (-2.10%)
PFE   49.78 (+0.42%)
NFLX   226.61 (-2.95%)
S&P 500   4,124.49 (-0.38%)
DOW   32,798.30 (-0.10%)
QQQ   316.20 (-1.41%)
AAPL   164.01 (-0.52%)
MSFT   279.09 (-0.44%)
META   167.38 (-1.69%)
GOOGL   115.95 (-1.15%)
AMZN   136.83 (-1.85%)
TSLA   853.33 (-2.06%)
NVDA   170.96 (-3.92%)
NIO   19.37 (-3.97%)
BABA   92.07 (+1.35%)
AMD   96.21 (-3.86%)
MU   58.63 (-4.59%)
T   18.17 (+0.94%)
CGC   3.02 (-7.93%)
GE   75.82 (+0.85%)
F   15.50 (-1.77%)
DIS   107.34 (-1.62%)
AMC   22.92 (-4.34%)
PYPL   94.24 (-2.10%)
PFE   49.78 (+0.42%)
NFLX   226.61 (-2.95%)
NYSEAMERICAN:ISR

Isoray - ISR Stock Forecast, Price & News

$0.37
-0.01 (-2.63%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.37
$0.40
50-Day Range
N/A
52-Week Range
$0.25
$0.75
Volume
154,538 shs
Average Volume
356,132 shs
Market Capitalization
$52.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.25

Isoray MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
237.7% Upside
$1.25 Price Target
Short Interest
Healthy
1.00% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$27,631 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.04) to ($0.02) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars

ISR stock logo

About Isoray (NYSEAMERICAN:ISR) Stock

Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.

Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

ISR Stock News Headlines

Form 424B5 Isoray, Inc. - StreetInsider.com
Form 8-K Isoray, Inc. For: Apr 11 - StreetInsider.com
See More Headlines
Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

ISR Company Calendar

Last Earnings
11/10/2021
Today
8/09/2022
Next Earnings (Estimated)
9/19/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:ISR
Previous Symbol
NYSEMKT:ISR
Employees
61
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$1.25
High Stock Price Forecast
$1.25
Low Stock Price Forecast
$1.25
Forecasted Upside/Downside
+237.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-3,390,000.00
Pretax Margin
-48.05%

Debt

Sales & Book Value

Annual Sales
$10.05 million
Book Value
$0.48 per share

Miscellaneous

Free Float
138,481,000
Market Cap
$52.57 million
Optionable
Not Optionable
Beta
0.92

Key Executives

  • Ms. Lori A. Holmes-Woods (Age 60)
    CEO & Director
    Comp: $371.19k
  • Ms. Jennifer Streeter (Age 52)
    COO & VP of HR
    Comp: $266.35k
  • Mr. William A. Cavanagh III (Age 56)
    Chief R&D Officer
    Comp: $253.34k
  • Mr. Jonathan R. Hunt (Age 55)
    CFO & Co-Principal Financial Officer
  • Mr. Mark J. Austin CPA (Age 35)
    VP of Fin., Controller, Co-Principal Financial, Principal Accounting Officer & Sec.
  • Ms. Krista Cline (Age 40)
    Sr. Director of Operations & Corp. Sec.













ISR Stock - Frequently Asked Questions

Should I buy or sell Isoray stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Isoray in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ISR shares.
View ISR analyst ratings
or view top-rated stocks.

What is Isoray's stock price forecast for 2022?

1 brokerages have issued 12-month price targets for Isoray's stock. Their ISR share price forecasts range from $1.25 to $1.25. On average, they anticipate the company's share price to reach $1.25 in the next year. This suggests a possible upside of 237.7% from the stock's current price.
View analysts price targets for ISR
or view top-rated stocks among Wall Street analysts.

How has Isoray's stock performed in 2022?

Isoray's stock was trading at $0.38 at the beginning of the year. Since then, ISR shares have decreased by 2.6% and is now trading at $0.3701.
View the best growth stocks for 2022 here
.

When is Isoray's next earnings date?

Isoray is scheduled to release its next quarterly earnings announcement on Monday, September 19th 2022.
View our ISR earnings forecast
.

How were Isoray's earnings last quarter?

Isoray, Inc. (NYSEAMERICAN:ISR) posted its quarterly earnings data on Wednesday, November, 10th. The healthcare company reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The healthcare company earned $2.56 million during the quarter, compared to the consensus estimate of $2.58 million. Isoray had a negative trailing twelve-month return on equity of 9.19% and a negative net margin of 48.05%.

What other stocks do shareholders of Isoray own?

What is Isoray's stock symbol?

Isoray trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ISR."

Who are Isoray's major shareholders?

Isoray's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Perkins Capital Management Inc. (2.05%) and Taylor & Morgan Wealth Management LLC (0.55%). Insiders that own company stock include Jonathan Robert Hunt, Lori A Woods, Mark John Austin, Michael Krachon, Philip J Vitale and William Cavanagh.
View institutional ownership trends
.

How do I buy shares of Isoray?

Shares of ISR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Isoray's stock price today?

One share of ISR stock can currently be purchased for approximately $0.37.

How much money does Isoray make?

Isoray (NYSEAMERICAN:ISR) has a market capitalization of $52.57 million and generates $10.05 million in revenue each year. The healthcare company earns $-3,390,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis.

How many employees does Isoray have?

Isoray employs 61 workers across the globe.

How can I contact Isoray?

Isoray's mailing address is 350 Hills St Ste 106, RICHLAND, WA 99354-5511, United States. The official website for the company is isoray.com. The healthcare company can be reached via phone at (509) 375-1202, via email at dbabcock@isoray.com, or via fax at 509-267-3670.

This page (NYSEAMERICAN:ISR) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.